Cerebral hypoperfusion in post-COVID-19 cognitively impaired subjects revealed by arterial spin labeling MRI.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
10 04 2023
10 04 2023
Historique:
received:
23
12
2022
accepted:
24
03
2023
medline:
12
4
2023
entrez:
10
4
2023
pubmed:
11
4
2023
Statut:
epublish
Résumé
Cognitive impairment is one of the most prevalent symptoms of post Severe Acute Respiratory Syndrome COronaVirus 2 (SARS-CoV-2) state, which is known as Long COVID. Advanced neuroimaging techniques may contribute to a better understanding of the pathophysiological brain changes and the underlying mechanisms in post-COVID-19 subjects. We aimed at investigating regional cerebral perfusion alterations in post-COVID-19 subjects who reported a subjective cognitive impairment after a mild SARS-CoV-2 infection, using a non-invasive Arterial Spin Labeling (ASL) MRI technique and analysis. Using MRI-ASL image processing, we investigated the brain perfusion alterations in 24 patients (53.0 ± 14.5 years, 15F/9M) with persistent cognitive complaints in the post COVID-19 period. Voxelwise and region-of-interest analyses were performed to identify statistically significant differences in cerebral blood flow (CBF) maps between post-COVID-19 patients, and age and sex matched healthy controls (54.8 ± 9.1 years, 13F/9M). The results showed a significant hypoperfusion in a widespread cerebral network in the post-COVID-19 group, predominantly affecting the frontal cortex, as well as the parietal and temporal cortex, as identified by a non-parametric permutation testing (p < 0.05, FWE-corrected with TFCE). The hypoperfusion areas identified in the right hemisphere regions were more extensive. These findings support the hypothesis of a large network dysfunction in post-COVID subjects with cognitive complaints. The non-invasive nature of the ASL-MRI method may play an important role in the monitoring and prognosis of post-COVID-19 subjects.
Identifiants
pubmed: 37037833
doi: 10.1038/s41598-023-32275-3
pii: 10.1038/s41598-023-32275-3
pmc: PMC10086005
doi:
Substances chimiques
Spin Labels
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
5808Informations de copyright
© 2023. The Author(s).
Références
Neuroimage. 2009 Jan 1;44(1):83-98
pubmed: 18501637
Tomography. 2022 Jan 17;8(1):229-244
pubmed: 35076603
Magn Reson Med. 2011 Apr;65(4):1173-83
pubmed: 21337417
Eur J Nucl Med Mol Imaging. 2021 Jul;48(8):2543-2557
pubmed: 33452633
Hum Brain Mapp. 2002 Jan;15(1):1-25
pubmed: 11747097
J Neurol. 2022 Jul;269(7):3400-3412
pubmed: 35249144
Nat Med. 2021 Apr;27(4):601-615
pubmed: 33753937
Neuroimage. 2014 Nov 15;102 Pt 1:49-59
pubmed: 23792219
Brain Commun. 2022 Jan 19;4(1):fcab295
pubmed: 35128398
Lancet Psychiatry. 2021 May;8(5):416-427
pubmed: 33836148
Neuroimage. 2004;23 Suppl 1:S220-33
pubmed: 15501093
Brain. 2020 Oct 1;143(10):3104-3120
pubmed: 32637987
Eur J Neurol. 2020 Dec;27(12):2651-2657
pubmed: 32881133
Brain Behav Immun. 2021 May;94:138-147
pubmed: 33639239
Continuum (Minneap Minn). 2021 Dec 1;27(6):1586-1601
pubmed: 34881727
Aging Clin Exp Res. 2022 Feb;34(2):375-382
pubmed: 34313961
J Nucl Med. 2021 Jul 1;62(7):910-915
pubmed: 33789937
J Magn Reson Imaging. 2022 Dec 6;:
pubmed: 36472248
Parkinsonism Relat Disord. 2019 Aug;65:105-110
pubmed: 31147224
Eur J Neurol. 2021 Oct;28(10):3245-3253
pubmed: 33576150
Lancet. 2021 Jan 16;397(10270):220-232
pubmed: 33428867
PLoS One. 2015 May 06;10(5):e0123975
pubmed: 25946055
Magn Reson Med. 2019 Jun;81(6):3734-3744
pubmed: 30828873
Nature. 2022 Apr;604(7907):697-707
pubmed: 35255491
J Neurol. 2022 Feb;269(2):587-596
pubmed: 34386903
Brain Behav. 2022 Apr;12(4):e2513
pubmed: 35290729
Viruses. 2021 Nov 15;13(11):
pubmed: 34835088
J Neurol Sci. 2022 Oct 15;441:120355
pubmed: 35994869
Brain. 2021 May 7;144(4):1263-1276
pubmed: 33822001
Brain Behav Immun. 2022 Mar;101:93-135
pubmed: 34973396
J Neurol. 2021 Oct;268(10):3569-3573
pubmed: 33709220
Brain. 2011 Mar;134(Pt 3):845-55
pubmed: 21310726
Clin Infect Dis. 2021 Sep 7;73(5):e1089-e1098
pubmed: 33220049
JAMA Netw Open. 2021 Oct 1;4(10):e2128568
pubmed: 34643720
J Am Geriatr Soc. 2005 Apr;53(4):695-9
pubmed: 15817019
JAMA Netw Open. 2021 Oct 1;4(10):e2130645
pubmed: 34677597
Magn Reson Med. 2015 Jan;73(1):102-16
pubmed: 24715426
J Alzheimers Dis. 2021;82(3):883-898
pubmed: 34092646
Neuroimage. 2009 Apr 15;45(3):795-809
pubmed: 19162204
Continuum (Minneap Minn). 2018 Jun;24(3, BEHAVIORAL NEUROLOGY AND PSYCHIATRY):704-726
pubmed: 29851874
Eur J Nucl Med Mol Imaging. 2021 Aug;48(9):2823-2833
pubmed: 33501506
Neurol Sci. 2021 Aug;42(8):3423-3425
pubmed: 33763811
Eur Arch Psychiatry Clin Neurosci. 2012 Feb;262(1):69-77
pubmed: 21786091
Magn Reson Med. 1998 Sep;40(3):383-96
pubmed: 9727941
MMWR Morb Mortal Wkly Rep. 2020 Jul 31;69(30):993-998
pubmed: 32730238